Aidi Injection alters the expression profiles of MicroRNAs in human breast cancer cells

Journal of Traditional Chinese Medicine

Volumn 31, Issue 1, 2011, Pages 10-16

  Zhang, Hui ^a   Zhou, Qian Mei ^a   Lu, Yi Yu ^a   Du, Jia ^a   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Aidi Injection; Breast cancer cells; miRNA

Indexed keywords

AIDI; ANTINEOPLASTIC AGENT; LIPOSOME; MESSENGER RNA; MICRORNA; MICRORNA 126; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; COMPUTER PROGRAM; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 79956062622     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(11)60003-4     Document Type: Article

References (37)

1. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol 2002; 29: 563-574. (Pubitemid 36134979)
2. Xie ZF. Selected terms in traditional Chinese medicine and their interpretations. CJIM 2001; 7: 64-66.
3. World Health Organization: WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region. 2007: 204.
4. Duan YL, Fan XH , Hou JQ. Clinical observation on effect of Aidi Injection in treating radiation injury of lung. China J Integr Chin West Med (Chin) 2004; 24: 256-257.
5. Xu K, Luo HY, Li LN. Clinical study on comprehensive treatment of primary liver cancer mainly with Chinese medicinal perfusion/embolization. China J Integr Chin West Med (Chin) 2005; 25: 299-302.
6. Tang L, Zeng FB, Wang T, Wu M. Effects of Aidi on hepatocellular carcinoma cells apoptosis. China Pharm.2006; 9: 198-200.
7. Hong Z, Pan LX, Chen J, Feng JF, Hang FL, Zheng XL. Traditional Chinese medicine Aidi parenteral solution with NP regimen for reversal of multidrug resistance in non-small cell lung cancer with P-gp overexpression. J Clin Med Prac 2005; 9: 30-33.
8. Lou HZ, Pan HM, Jin W. Clinical study on treatment of primary liver cancer by Aidi Injection combined with cool-tip radiofrequency ablation. China J Integ Trad West Med 2007; 27: 393-395.
9. Jia SW, Jia H, Tang HX, Xu K, Li J. Clinical study on effect of Aidi Injection in efficacy enhancing and toxicity reducing of radiotherapy and chemotherapy in patients of malignant tumour. J Mod Oncol 2007; 15: 854-856.
10. Bartel, DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
11. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
12. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
13. Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, Hu Q, et al. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci 2007; 98: 1845-1852. (Pubitemid 350002188)
14. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688. (Pubitemid 47552092)
15. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2007; 283: 1026-1033.
16. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 2007; 67: 11001-11011. (Pubitemid 350145930)
17. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. Engl J Med 2005; 353: 1768-1771.
18. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM,' Chisari FV, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919-922. (Pubitemid 47598616)
19. Lewis BP, Shih IH, Jones-Rhoades MW, Barrel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798. (Pubitemid 38058492)
20. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500. (Pubitemid 40617277)
21. Zhang J, Du YY, Lin YF, Chen YT, Yang L, Wang HJ, et al. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008; 377: 136-140.
22. Shivdasani RA. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006; 108: 3646-3653. (Pubitemid 44864540)
23. Ross JS, Carlson JA, Brock G. miRNA: the new gene silencer. Am J Clin Pathol 2007; 128: 830-836. (Pubitemid 350133996)
24. Wu C, Chen F, Rushing JW, Wang X, Kim HJ, Huang G, et al. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines. J Med Food 2006; 9: 55-61. (Pubitemid 44153618)
25. Sartippour MR, Seeram NP, Heber D, Hardy M, Norris A, Lu Q, et al. Rabdosia rubescens inhibits breast cancer growth and angiogenesis. Int J Oncol 2005; 26: 121-127.
26. Lau FY, Chui CH, Gambari R, Kok SH, Kan KL, Cheng GY, et al. Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells. Int J Mol Med 2005; 16: 1157-1162.
27. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070. (Pubitemid 41161233)
28. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261. (Pubitemid 43271657)
29. Tam W, Dahlberg JE. MiR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer 2006; 45: 211-212.
30. Reddy SD, Ohshiro K, Rayala SK, Kumar R. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 2008; 68: 8195-8200.
31. Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 2006; 26: 8191-8201.
32. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647. (Pubitemid 40343076)
33. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21: 1025-1030. (Pubitemid 46686471)
34. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007; 67: 9762-9770. (Pubitemid 47621223)
35. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
36. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 2009; 284: 5731-5741.
37. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 2007; 282: 1479-1486. (Pubitemid 47076526)